U.S. taxpayer dollars will no longer fund “Frankenvirus” experiments in secretive biolabs located in far-flung corners of the world. President Donald Trump has dropped the hammer on the industry developed by Dr. Anthony Fauci and issued an immediate ban on gain-of-function research.
More than five years after COVID-19 swept the globe, President Trump has signed a landmark executive order late Monday, banning all federal funding for gain-of-function virus research and calling out Dr. Fauci by name for his role in promoting and funding the controversial experiments that many now believe sparked the pandemic.
The order immediately ends current and future funding for such research and stresses that this action aims to prevent lab-related incidents, citing controversial projects by EcoHealth Alliance and the Wuhan Institute of Virology as outlaw operations and contributors to the pandemic.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
You can unsubscribe any time. By subscribing you agree to our Terms of Use
The executive order also pauses all pathogen research until new safety policies are developed. While some scientists, including former CDC Director Dr. Robert Redfield, support the lab-leak theory, Dr. Anthony Fauci continues to claim innocence, maintaining that the virus emerged naturally in the Wuhan wet market just miles from where his risky experimentation was taking place in the Wuhan Institute of Virology.
Tulsi Gabbard Exposes Fauci’s Ukraine Biolabs as Adrenochrome Factories
Fauci’s increasingly tenuous position is weakened by the fact he is on record “predicting” that a “surprise” pandemic would occur during the first Trump administration.
This executive order marks a significant shift in U.S. policy on funding high-risk virological research, reflecting growing concerns over the potential for lab-related incidents and the need for stricter oversight and regulation.
Critics have long questioned U.S. funding and oversight of overseas research, with a Defense Department report revealing significant gaps in tracking gain-of-function activities and spending.
Secretary Robert F. Kennedy Jr. and other officials praised the move as a critical step to prevent future pandemics.
The White House emphasized that the order aims to protect Americans from dangerous gain-of-function research that manipulates viruses and other biological agents and toxins, but it does not impede productive biological research that will ensure the United States maintains readiness against biological threats and continues to drive global leadership in biotechnology, biosecurity, and health research.